The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
Purpose: To evaluate the effect of hyperuricemia on clinical outcomes of renal transplant recipients (RTRs). Methods: A literature search of PubMed, Cochrane, Embase was conducted up to March 20, 2020. The primary outcome was the estimated glomerular filtration rate (eGFR). The second outcomes were...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31620 |
_version_ | 1797763274931961856 |
---|---|
author | hui Yang Qing Chen Aiwen Huang Xiaojia Yu Gang Chen Xiaopeng Hu Wei Wang Hang Liu Xiaodong Zhang Lihong Liu |
author_facet | hui Yang Qing Chen Aiwen Huang Xiaojia Yu Gang Chen Xiaopeng Hu Wei Wang Hang Liu Xiaodong Zhang Lihong Liu |
author_sort | hui Yang |
collection | DOAJ |
description | Purpose: To evaluate the effect of hyperuricemia on clinical outcomes of renal transplant recipients (RTRs). Methods: A literature search of PubMed, Cochrane, Embase was conducted up to March 20, 2020. The primary outcome was the estimated glomerular filtration rate (eGFR). The second outcomes were the risk of graft loss, death, cardiovascular event and the level of triglyceride. The following search terms were utilized: ((Hyperuricemic group) OR (Hyperuricaemia) OR (Hyperuric) OR (Urea acid) OR (Uric acid) OR (Acid urate) OR (Urate) OR (Gout)) and ((Transplantation) OR (Transplantations) OR (Transplant) OR (Transplants) OR (Graft)). Results: 28 studies with 18224 patients were eligible for inclusion. There was no significant difference in eGFR (<12 months, p=0.07), the risk of graft loss (<60 months, p=0.07) and death (<60months, p=0.19) between the hyperuricemic and normouricemic group in the early post-transplantation period. But increased uric acid levels contributed to the long-term decline of eGFR, the risk of graft loss and death increased after transplantation. Hyperuricemia increased the risk of cardiovascular event with no significant difference in the level of triglyceride between the two groups. Conclusions: Increased uric acid levels contributed to the long-term decline of eGFR, increased risk of graft loss and death after transplantation. Although there was no significant effect on triglyceride, hyperuricemia increased the risk of cardiovascular event. |
first_indexed | 2024-03-12T19:40:14Z |
format | Article |
id | doaj.art-4c8492cf06f3421b8d652156ab14d403 |
institution | Directory Open Access Journal |
issn | 1482-1826 |
language | English |
last_indexed | 2024-03-12T19:40:14Z |
publishDate | 2021-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Journal of Pharmacy & Pharmaceutical Sciences |
spelling | doaj.art-4c8492cf06f3421b8d652156ab14d4032023-08-02T03:54:20ZengFrontiers Media S.A.Journal of Pharmacy & Pharmaceutical Sciences1482-18262021-06-0124310.18433/jpps31620The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysishui YangQing ChenAiwen HuangXiaojia YuGang ChenXiaopeng HuWei WangHang LiuXiaodong ZhangLihong LiuPurpose: To evaluate the effect of hyperuricemia on clinical outcomes of renal transplant recipients (RTRs). Methods: A literature search of PubMed, Cochrane, Embase was conducted up to March 20, 2020. The primary outcome was the estimated glomerular filtration rate (eGFR). The second outcomes were the risk of graft loss, death, cardiovascular event and the level of triglyceride. The following search terms were utilized: ((Hyperuricemic group) OR (Hyperuricaemia) OR (Hyperuric) OR (Urea acid) OR (Uric acid) OR (Acid urate) OR (Urate) OR (Gout)) and ((Transplantation) OR (Transplantations) OR (Transplant) OR (Transplants) OR (Graft)). Results: 28 studies with 18224 patients were eligible for inclusion. There was no significant difference in eGFR (<12 months, p=0.07), the risk of graft loss (<60 months, p=0.07) and death (<60months, p=0.19) between the hyperuricemic and normouricemic group in the early post-transplantation period. But increased uric acid levels contributed to the long-term decline of eGFR, the risk of graft loss and death increased after transplantation. Hyperuricemia increased the risk of cardiovascular event with no significant difference in the level of triglyceride between the two groups. Conclusions: Increased uric acid levels contributed to the long-term decline of eGFR, increased risk of graft loss and death after transplantation. Although there was no significant effect on triglyceride, hyperuricemia increased the risk of cardiovascular event.https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31620 |
spellingShingle | hui Yang Qing Chen Aiwen Huang Xiaojia Yu Gang Chen Xiaopeng Hu Wei Wang Hang Liu Xiaodong Zhang Lihong Liu The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis Journal of Pharmacy & Pharmaceutical Sciences |
title | The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis |
title_full | The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis |
title_fullStr | The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis |
title_full_unstemmed | The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis |
title_short | The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis |
title_sort | impact of hyperuricemia on long term clinical outcomes of renal transplant recipients a systematic review and meta analysis |
url | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31620 |
work_keys_str_mv | AT huiyang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT qingchen theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT aiwenhuang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT xiaojiayu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT gangchen theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT xiaopenghu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT weiwang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT hangliu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT xiaodongzhang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT lihongliu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT huiyang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT qingchen impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT aiwenhuang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT xiaojiayu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT gangchen impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT xiaopenghu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT weiwang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT hangliu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT xiaodongzhang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis AT lihongliu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis |